ArticleBrain pathology (Zurich, Switzerland)2026
Complement receptor C3aR marks heterogeneous tumor-associated macrophage states associated with improved survival in IDH-wildtype glioblastoma.
Marion Imara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.